Atika Capital Management LLC Invitae Corp Transaction History

Atika Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $528,960 - $910,880	-16,000 Reduced 17.02%	78,000 $2.98 Million
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $234,540 - $344,400	-6,000 Reduced 6.0%	94,000 $3.93 Million
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $2.84 Million - $4.47 Million	100,000 New	100,000 $4.34 Million
Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $0 - $0	0 New	0 $0
Q2 2019 Aug 12, 2019	SELL	$17.37 - $26.27 $3.21 Million - $4.86 Million	-185,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$10.65 - $25.75 $1.97 Million - $4.76 Million	185,000 New	185,000 $4.33 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.